News
In a report released today, Eric Joseph from J.P. Morgan maintained a Hold rating on Verve Therapeutics (VERV – Research Report), with a price ...
Complementary Leadership Expands Full-Stage Investment Platform Dr. Matt Cohen joins from JP Morgan Asset Management (JPMAM), where he was a Managing Director and spent two decades investing in ...
7d
Pharmaceutical Technology on MSNBluebird bio reaffirms Carlyle deal as Ayrmid misses deadlineBluebird has reaffirmed its support for a proposed acquisition after Ayrmid failed to deliver a binding offer by the extended ...
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announces CEO Dr. Ryan Saadi, MD, MPH, will participate in BioNJ’s ...
11d
BuzzFeed on MSNSpicy Enoki MushroomsPresident Donald Trump authorized the military to take control of federal lands along the U.S.-Mexico border to bolster immigration enforcement in an executive order signed Friday night. It comes amid ...
With another JP Morgan in the rearview mirror ... Andrew Obershain, CEO of bluebird bio, said as much on stage. A year before the FDA approved his company’s gene therapy for sickle cell ...
With the discontinuation of danuglipron, Pfizer is now down to one clinical-stage obesity asset: the oral GIP analog ...
16d
Distractify on MSNJPMorgan CEO Jamie Dimon Is Rich in Life and at Home — Let's Meet His WifeJamie Dimon married his wife, Judith Kent, back in 1983. Judith is a deeply committed philanthropist with a background in organizational psychology.
Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...
Robin Sharma, the self-help guru and author of The 5 a.m. Club, is up—“4 a.m. is the new 5 a.m.” he told GQ recently—for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results